3,519
Views
17
CrossRef citations to date
0
Altmetric
Editorial

Triple combinations in chronic obstructive pulmonary disease – is three better than two?

&

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Mario Cazzola, Paola Rogliani, Rossella Laitano, Luigino Calzetta & Maria Gabriella Matera. (2022) Beyond Dual Bronchodilation – Triple Therapy, When and Why. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 165-180.
Read now
Luigino Calzetta, Maria Gabriella Matera, Paola Rogliani & Mario Cazzola. (2020) The role of triple therapy in the management of COPD. Expert Review of Clinical Pharmacology 13:8, pages 865-874.
Read now
Tomoko Betsuyaku, Motokazu Kato, Keisaku Fujimoto, Akihiro Kobayashi, Tomoyuki Hayamizu, Hideki Hitosugi, Gerald Hagan, Mark H James & Paul W Jones. (2018) A randomized trial of symptom-based management in Japanese patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2409-2423.
Read now
Xiaoyu Liu, Cuiqing Ma, Xiaoyu Wang, Wenjing Wang, Zhu Li, Xiansheng Wang, Pengyu Wang, Wuzhuang Sun & Baojian Xue. (2017) Hydrogen coadministration slows the development of COPD-like lung disease in a cigarette smoke-induced rat model. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1309-1324.
Read now
Nicola A Hanania, Suzanne C. Lareau & Barbara P. Yawn. (2017) Safety of inhaled long-acting anti-muscarinic agents in COPD. Postgraduate Medicine 129:5, pages 500-512.
Read now
Mario Cazzola, Paola Rogliani, Josuel Ora & Maria Gabriella Matera. (2016) Treatment options for moderate-to-very severe chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 17:7, pages 977-988.
Read now
Masaki Miyazaki, Hidetoshi Nakamura, Saeko Takahashi, Shotaro Chubachi, Mamoru Sasaki, Mizuha Haraguchi, Hideki Terai, Makoto Ishii, Koichi Fukunaga, Sadatomo Tasaka, Kenzo Soejima, Koichiro Asano & Tomoko Betsuyaku. (2015) The reasons for triple therapy in stable COPD patients in Japanese clinical practice. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 1053-1059.
Read now
Maria Gabriella Matera, Paola Rogliani & Mario Cazzola. (2015) QVA149 (indacaterol/glycopyrronium) for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 16:7, pages 1079-1090.
Read now

Articles from other publishers (9)

Mario Cazzola, Luigino Calzetta, Paola Rogliani & Maria Gabriella Matera. (2019) Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses. Pulmonary Therapy 5:2, pages 117-126.
Crossref
Beth Hahn, Michael Hull, Cori Blauer-Peterson, Ami R. Buikema, Riju Ray & Richard H. Stanford. (2018) Rates of escalation to triple COPD therapy among incident users of LAMA and LAMA/LABA. Respiratory Medicine 139, pages 65-71.
Crossref
Han Ni, Aung Htet & Soe Moe. (2017) Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD). Cochrane Database of Systematic Reviews 2017:6.
Crossref
A.J. Ferreira, A. Reis, N. Marçal, P. Pinto & C. Bárbara. (2016) COPD: A stepwise or a hit hard approach?. Revista Portuguesa de Pneumologia (English Edition) 22:4, pages 214-221.
Crossref
J. Ferreira, M. Drummond, N. Pires, G. Reis, C. Alves & C. Robalo-Cordeiro. (2016) Optimal treatment sequence in COPD: Can a consensus be found?. Revista Portuguesa de Pneumologia (English Edition) 22:1, pages 39-49.
Crossref
Clive Page & Mario Cazzola. 2017. Pharmacology and Therapeutics of Asthma and COPD. Pharmacology and Therapeutics of Asthma and COPD 197 212 .
Maria Gabriella Matera & Mario Cazzola. 2017. Pharmacology and Therapeutics of Asthma and COPD. Pharmacology and Therapeutics of Asthma and COPD 41 62 .
Mario Cazzola & Maria Gabriella Matera. 2017. Pharmacology and Therapeutics of Asthma and COPD. Pharmacology and Therapeutics of Asthma and COPD 117 129 .
Han Ni, Soe Moe, Zay Soe, Kay Thi Myint & K Neelakantan Viswanathan. (2015) Combined aclidinium bromide and long-acting beta 2 -agonist for COPD . Cochrane Database of Systematic Reviews.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.